UBS Maintains Neutral on Incyte, Raises Price Target to $113

Benzinga Newsdesk www.benzinga.com Positive 73.8%

Neg 0% Neu 0% Pos 73.8%

UBS analyst Ashwani Verma maintains Incyte (NASDAQ:INCY) with a Neutral and raises the price target from $103 to $113.

Comments

No comments yet. Be the first!